COSAR is a collaboration of people with a particular interest in adenomyosis and core outcomes. The steering group for COSAR represents patients, gynaecologists with different fields of special interest in adenomyosis, such as imaging, surgery or infertility, researchers, physiotherapist and hormone specialists. All are passionate about improving research on adenomyosis and all are committing to this project in their free time, without any financial gratification.
We are committed to improving the quality of research into adenomyosis and making that research more relevant to women. We have seen the necessity for core outcomes sets in adenomyosis and have seen their success in other gynaecological conditions.
Tina Tellum, MD, PhD
Gynaecology consultant at Oslo University Hospital, Norway. Specialist in imaging of adenomyosis. Lead project manager.
Joel Naftalin, MD
Consultant Gynaecologist at University College London Hospital, UK. Thesis on ultrasound of adenomyosis and clinical features, clinical and academic passion in adenomyosis since. Project manager.
Prof. Charles Chapron
Head of Department of Obstetrics, Gynecology and Reproductive Medicine at Cochin University Hospital (Paris, France). Has held central positions in numerous societies (ESHRE, AAGL, SEUD, SFEG, SIFCP, EEL). His academic and clinic contributions on adenomyosis and endometriosis are enormous.
Prof. Sun-Wei Guo
Professor at Shanghai OB/GYN Hospital, and the Department of Biochemistry and Molecular Biology, Fudan University Shanghai College of Medicine. Adjunct professor at Michigan State University College, USA. He is credited as being the first to propose and provide evidence that endometriosis is an epigenetic disease. He is an associated editor for several journals and his publications have contributed significantly to our knowledge on endometriosis.
Ertan Saridogan, PhD
Consultant in Reproductive Medicine and Minimal Access Surgery at University College London Hospitals. Past President of the British Society for Gynaecological Endoscopy, current President of International Society of Reproductive Surgery. In charge of the Scientific Programme of ESGE annual meetings, editor for several scientific journals.
Prof. Zephne van der Spuy
Emeritus Professor and Head of Postgraduate Education in the Department of Obstetrics and Gynaecology at the University of Cape Town. She was the president of both the College of Medicine and College of Obstetricians and Gynecologists in South Africa. She has contributed to guidelines and core outcome projects. Her research interests are in genetics and phenotype of benign gynaecological disorders such as uterine fibroids and PCOS, contraception and quality of life.
Prof. Margit Dueholm
Consultant Gynecologist and adjunct professor at University of Aarhus, Danmark. Her field of clinical and scientific interest is gynecological imaging, including adenomyosis, endometriosis and malignant disease. She has published significantly in this field and is a highly appreciated member of several working committees and consensus groups.
Martin Hirsch, MD
Consultant Gynaecologist at Oxford University Hospitals, UK. Special interest in core outcome sets and endometriosis. Managing team member.
Prof. Malcolm G. Munro
Clinical Professor at the University of California, Los Angeles (UCLA). Chair of the FIGO Menstrual Disorders Committee, in charge of FIGO classification of uterine fibroids and adenomyosis. Author of textbooks and substantial scientific literature on uterine disease. He is also the founder of the Women's Health Research Collaborative, a multi-stakeholder Initiative around unmet women's health needs.
Elisabeth Raasholm Larby
Elisabeth is living with adenomyosis and represents the patients in this panel. She lives in Norway and is currently the leader of the Norwegian Endometriosis Association. She has contributed significantly to raising awareness on endometriosis and adenomyosis amongst politicians, health care professionals and the general public. As a public research partner, she is involved in many endo/adeno-related projects in Norway.
Lone Hummelshoj (res.)
Lone contributed significantly to COSAR during her active time as a chief executive of the World Endometriosis Society (WES) and editor-in-chief of endometriosis.org. She has published more than 45 papers and chapters in endometriosis and contributed to multiple guidelines and consensus works. A powerful patient advocate with a long track record of raising awareness of endometriosis and adenomyosis.